Ecoeos
Ecoeos answers the question of who is at risk from environmental toxins and how people can protect themselves and their families.
- Stage Prototype Ready
- Industry Medical Devices and Equipment
- Location San Francisco, CA, USA
- Currency USD
- Founded July 2010
- Employees 3
- Website ecoeos.com
Company Summary
Ecoeos develops clinically-validated DNA tests to measure personal susceptibiilty to environmental toxins. Ecoeos' first product is a mail-in genetic test that reveals a person's mercury susceptibility. Mercury, a vile neurotoxin, can harm developing fetuses and children. Future products focus on toxins such as lead and pesticides. Surveys (N=1,100) indicate early adopters are 15M women of reproductive age who are environmentally sensitive.
Team
-
Dr. Gregory StockCEO/Founder
Founder Signum Biosciences, Founder, Program on Medicine & Technology at UCLA's Medical School. PhD Biophysics, Johns Hopkins; MBA, Harvard, best selling author
-
Lisa ConteChairman/Founder
CEO, Napo Pharmaceuticals, CEO, Shaman Pharmaceuticals.
BS, Pharmacology, UCSD, MBA, Dartmouth -
David Ewing DuncanStrategic Advisor/Founder
Award-winning journalist (NYTs, NPR, Fortune) and bestselling author. Founding Director of the Center for Life Science Policy, UC Berkeley
-
Margaret ColesChief Marketing Officer/Advisor
Led product launches at GSK, Wyeth, Chevrolet, Zoomerang, Healthline and Wageworks. Degree in Marketing Metrics, Wharton
-
Christine JanaeVP Customer Experience and Design/Advisor
Experienced in consumer and web product development. Completed major projects for Mayo Clinic, Philips, HP, Razorfish, Hasbro, and Schick.
BFA, University of Washington
Advisors
-
Matthew Rossiter, Fenwick and WestLawyerUnconfirmed
Previous Investors
-
Various angel investorsUnconfirmed
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.